LC-MS bioanalysis service
Our LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
We continue to create new method development techniques, such as small molecule biomarkers by LC-MS/MS and apply novel technologies to help answer your analytical challenges. We provide small molecule drugs and biomarker analysis for pharmacokinetic (PK) and pharmacodynamics (PD) determinations from discovery support through to regulated GLP preclinical and GCP clinical studies. Flexible services include: Fast method development / analysis for discovery compounds Method development and validation for GLP TK studies and GCP clinical trials Fast turnaround for Phase I Clinical Studies Biomarkers by LC-MS/MS Pharmacokinetic data analysis using validated software systems (e.g. WinNonlin,) Logistical support for clinical sample management including sample collection kit production and supply of sampling kits, labels, investigator manual and shipping Data management using LIMS or specialist software
Resolian broadens horizons and expertise with its expansion into China
Resolian, formerly known as Alliance Pharma Inc. and Drug Development Solutions Ltd., excels at delivering specialized services in the analytical and bioanalytical space. Join CEO, Patrick Bennett, as he discusses the mission, vision, and values of the new name. Bennett provides a look into the strategy behind the company’s expansion into the Chinese market, describing the unique expertise housed within each of its four global laboratories, and how the company ensures synergy and harmonization between them.
This video was filmed at AAPS 2023 PharmSci 360.
Want the latest expert interviews, articles, webinars, virtual summits and more direct to your inbox? Become a SelectScience member for free today>>
Trusted bioanalytical experts to support your trials
Resolian specializes in providing comprehensive support for bioanalytical assay development, validation, and sample analysis, spanning the entire spectrum from early drug evaluation to clinical trials. The flexibility and agility of Resolian sets it apart, ensuring it can cater to specific demands. In this video, see how it is the right size and shape to adapt to the diverse needs of its clients and how it is committed to evolving and growing to better serve its partners in the world of pharmaceutical research.
This video was filmed at AAPS 2023 PharmSci 360.
Want the latest expert interviews, articles, webinars, virtual summits and more direct to your inbox? Become a SelectScience member for free today>>
Resolian acquires China-based bioanalytical CRO Denali Medpharma
Resolian can now initiate projects on four continents and easily transfer validated methods across labs
